Staff

TOP 5 publications:

1. Gründer G, Brand M, Mertens L, Jungaberle H, Kärtner L, Scharf DJ, Spangemacher M, Wolff M. Treatment with psychedelics is psychotherapy: beyond reductionism.Lancet Psychiatry. 2024 11(3):231-236. Epub 2023 Dec 12.
2. Mertens L, Betzler F, Brand M, Evens R, Jungaberle A, Jungaberle H, Kärtner L, Majic T, Schmitz C, Ströhle A, Scharf D, Spangemacher M, Wolff M, Assadi Z, Bahri S, Becher L, Färber LV, Harder H, Kirchen N, Kulakova E, Kunz LC, Meijer A, Rohrmoser B, Wellek S, Berger M, Koslowski M, Gründer G. Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression (EPIsoDE): 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial.Psychother Psychosom. 2026 May 27. [Epub ahead of print]:1-28.
3. Mertens L, Koslowski M, Betzler F, Brand M, Evens R, Kärtner L, Jungaberle A, Jungaberle H, Majic T, Schmitz C, Ströhle A, Scharf D, Spangemacher M, Wolff M, Assadi Z, Bahri S, Becher L, Färber LV, Kirchen N, Kulakova E, Kunz L, Meijer A, Rohrmoser B, Wellek S, Berger M, Gründer G. Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression: The EPISODE Randomized Clinical Trial.JAMA Psychiatry. 2026 83(5):448-460. Epub 2026 Mar 18.
4. Wolff M, Rutrecht H, Mertens L, Meijer AA, Beck J, Pérez S, Gründer G, Dziobek I, Jungaberle H. Common factors in altered states: Understanding psychedelic therapy through the lens of Grawe's general change mechanisms.Psychol Rev. 2025 132(6):1467-1492. Epub 2025 Oct 9.
5. Wolff M, Evens R, Mertens LJ, Schmidt C, Beck J, Rutrecht H, Cherniak AD, Gründer G, Jungaberle H. Measuring psychotherapeutic processes in the context of psychedelic experiences: Validation of the General Change Mechanisms Questionnaire (GCMQ).J Psychopharmacol. 2024 38(5):432-457. Epub 2024 May 14.